COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients

NCT04689464 | Completed DMC

• 1 other identifier: 1120
• Study Type: observational
• Target: 450
• Locations: 1 country
• Sites: 1

Brief Summary

The covid-19 pandemic started to spread worldwide since December 2019. It promoted to an exaggerated psychological stress and anxiety in humans due to the intolerable symptoms higher than usual death of many infected patients. This study examines the corona related anxiety and if there is need for drug intervention to treat this anxiety. To answer these questions, a survey made to the hospitalized patients including sex, age, educational level, Marital state, and a standardized questionnaires (GAD-7 and PHQ-9) which has been validated and shown to possess good psychometric qualities in studies of participants from multiple populations.

Conditions

Covid19; Anxiety; Depression

Keywords

COVID19; Anxiety; Depression

Outcome Measures

Primary Outcomes (2)

• depression

  Depression measured by Patient Health Questionnaire-9 (PHQ-9) scale. Scoring: 5-9 mild;10-14 moderate; 15-19 moderately severe; \>20 severe. Minimum 0 maximum 27 points

  at the time of acute infection, average of 1 month

• anxiety

  Anxiety measured by General Anxiety Disorder-7 (GAD-7) scale. Scoring:5-9 mild; 10-14 moderate; \>15 severe. Minimum 0, maximum 21 points

  at the time of acute infection, average of 1 month

Study Arms (3)

mild covid

moderate covid

severe covid

Eligibility Criteria

• Age: 15 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

patients with covid19 diagnosed by their healthcare providers

You may qualify if:

• \- patients with COVID19 willing to participate in the study

You may not qualify if:

• unwilling unable to read or interact with standardized questionnaire unconscious

Sponsors & Collaborators

• Alhasan Mujtaba Al-Mudhaffer: lead
• University of Basrah: collaborator
• Ministry of Health, Iraq: collaborator

Study Sites (1)

AlFayhaa Teaching hospital

Basra, 99999, Iraq

Location

MeSH Terms

Conditions

COVID-19; Anxiety Disorders; Depression

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Mental Disorders; Behavioral Symptoms; Behavior

Study Officials

• Zainab N Abdul-nabi, M.Sc.

  University of Basrah

  STUDY DIRECTOR

• Hiba Dawood, M.Sc.

  University of Basrah

  STUDY DIRECTOR

• Qussay N Almaliki, Ph.D.

  AlFayhaa teaching hospital

  STUDY DIRECTOR

• Nadheera F Neamah

  University of Basrah

  STUDY DIRECTOR

• Dania Zydoon

  Al-Sader teaching hospital

  PRINCIPAL INVESTIGATOR

• Zainab Mahdi

  Al-Mawani general hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Clinical Pharmacy Specialist

Study Record Dates

• First Submitted: December 26, 2020
• First Posted: December 30, 2020
• Study Start: December 1, 2020
• Primary Completion: May 28, 2021
• Study Completion: June 1, 2021
• Last Updated: June 8, 2021

Record last verified: 2021-06

Locations

IR (1)